Stock PHXM PHAXIAM THERAPEUTICS S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart PHAXIAM Therapeutics S.A. Euronext Paris

Equities

PHXM

FR0011471135

Real-time Euronext Paris
Other stock markets
 08:00:13 29/04/2024 BST 		5-day change 1st Jan Change
2.9 EUR -1.69% Intraday chart for PHAXIAM Therapeutics S.A. -1.36% -36.96%
04-15 Phaxiam initiates trial in infective endocarditis CF
04-15 PHAXIAM Therapeutics Announces Enrolment of First Patient in the Phase 1 Study for the Treatment of Endocarditis Infections Caused by Staphylococcus Aureus CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
PHAXIAM THERAPEUTICS S.A.
Bio Therapeutic Drugs
-1.69%-1.36%-36.96%-61.84%-95.92% 19.13M
Neutral
Bearish
Bearish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. PHXM Stock
  4. PHXM Stock
  5. Charts PHAXIAM Therapeutics S.A.
  6. Comparison Chart